Immunicom’s Immunopheresis™ is designed to empower patients to best live their lives while receiving revolutionary cancer treatment.
Location: United States, California, San Diego
Total raised: $12.85M
Investors 1
| Date | Name | Website |
| - | Bootstrap ... | bootstrapv... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 01.10.2019 | Series B | $1.85M | - |
| 02.07.2019 | Series B | $11M | - |
Mentions in press and media 6
| Date | Title | Description | Source |
| 17.11.2021 | Terumo Blood and Cell Technologies and Immunicom Establish A... | The therapy aims to re-energize a patient's immune system to fight cancer tumors Initial commerciali... | en.prnasia... |
| 13.09.2021 | Zoom Video Communications : 2021 Zoomtopia Innovation Award ... | Customer Stories, Zoomtopia 2021 Zoomtopia Innovation Award Winners Zoom September 13, 20215 min ... | marketscre... |
| 23.03.2021 | Breakthrough Immunotherapy Earns First Regulatory Approval f... | SAN DIEGO--(BUSINESS WIRE)--Mar 23, 2021-- Immunicom, Inc., a global biotechnology company pioneeri... | oaoa.com/n... |
| 01.10.2019 | Immunicom Secures Additional $1.85M Bringing Series B to $12... | Immunicom, Inc., a San Diego, CA-based medical technology company providing a non-pharmaceutical sol... | finsmes.co... |
| 03.07.2019 | Immunicom raises $11M for cancer treatment device | Biotech company Immunicom, which has developed a non-pharmaceutical, late-stage cancer treatment, ha... | massdevice... |
| 02.07.2019 | Immunicom Raises $11M in Series B Funding | Immunicom, Inc., a San Diego, CA-based biotechnology company focused on advancing a non-pharmaceutic... | finsmes.co... |